Jakob Plum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jakob Plum has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Anette Müllertz
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark; Bioneer A/S, Kogle Allé 2, Hørsholm 2970, Denmark
8 shared publications - Thomas Rades
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
8 shared publications - Line Hagner Nielsen
Department of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kgs. Lyngby, Denmark
3 shared publications Sophie Strindberg
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
3 shared publications- Carsten Uhd Nielsen
Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55 DK-5230, Odense M, Denmark
2 shared publications - Henrik Palmelund
Department of Pharmacy, University of Copenhagen, 2100 Copenhagen, Denmark
2 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Elsevier in SSRN Electronic Journal
Bovine Serum Albumin-Mediated Effects on Colonic Solubility, Mucus Permeation, and Absorption of Celecoxib
Celecoxib was used as a model compound in fasted state simulated colonic fluid (FaSSCoF) to investigate equilibrium drug solubility (Seq), protein binding using rapid equilibrium dialysis (RED), flux and permeability (Papp) across porcine colonic mucus (PCM), and in vivo colonic absorption using a rat intracolonic instillation model. The primary focus was on the role of bovine serum albumin (BSA) as a solubilizing and binding constituent, while bile salts (sodium taurodeoxycholate, TDC) with lecithin and poloxamer 407 were included as comparative systems to evaluate how differences in solubilizer type influence celecoxib permeability and absorption. BSA demonstrated a pronounced solubilizing effect on celecoxib with a 1:1 molar binding ratio, increasing the apparent Seq from 5.1 µg/mL to 92 µg/mL in FaSSCoF containing 15 mg/mL BSA. Under these conditions, diffusion across PCM increased approximately seven-fold compared with FaSSCoF without BSA, accompanied by a four-fold increase in colonic absorption in vivo. In contrast, when celecoxib concentration was maintained constant and BSA was subsequently added to FaSSCoF, diffusion across PCM decreased up to ten-fold at BSA concentrations of 1.5 mg/mL, accompanied by an approximately 30% decrease in colonic absorption in vivo. This behavior is consistent with an increased BSA-bound fraction and a reduced free drug concentration available for transport. The addition of TDC with lecithin or poloxamer 407 similarly increased celecoxib diffusion across PCM and colonic absorption when celecoxib was dissolved at Seq in FaSSCoF, although no statistically significant differences were observed between the solubilizing systems. Overall, these findings demonstrate that solubilizing constituents in colonic fluids can substantially increase drug solubility, mucus permeation, and colonic absorption, highlighting the importance of accounting for protein–drug interactions when evaluating drug behavior in the colon.
- 29 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBovine Serum Albumin-Mediated Effects on Colonic Solubility, Mucus Permeation, and Absorption of Celecoxib
Celecoxib was used as a model compound in fasted state simulated colonic fluid (FaSSCoF) to investigate equilibrium drug solubility (Seq), protein binding using rapid equilibrium dialysis (RED), flux and permeability (Papp) across porcine colonic mucus (PCM), and in vivo colonic absorption using a rat intracolonic instillation model. The primary focus was on the role of bovine serum albumin (BSA) as a solubilizing and binding constituent, while bile salts (sodium taurodeoxycholate, TDC) with lecithin and poloxamer 407 were included as comparative systems to evaluate how differences in solubilizer type influence celecoxib permeability and absorption. BSA demonstrated a pronounced solubilizing effect on celecoxib with a 1:1 molar binding ratio, increasing the apparent Seq from 5.1 µg/mL to 92 µg/mL in FaSSCoF containing 15 mg/mL BSA. Under these conditions, diffusion across PCM increased approximately seven-fold compared with FaSSCoF without BSA, accompanied by a four-fold increase in colonic absorption in vivo. In contrast, when celecoxib concentration was maintained constant and BSA was subsequently added to FaSSCoF, diffusion across PCM decreased up to ten-fold at BSA concentrations of 1.5 mg/mL, accompanied by an approximately 30% decrease in colonic absorption in vivo. This behavior is consistent with an increased BSA-bound fraction and a reduced free drug concentration available for transport. The addition of TDC with lecithin or poloxamer 407 similarly increased celecoxib diffusion across PCM and colonic absorption when celecoxib was dissolved at Seq in FaSSCoF, although no statistically significant differences were observed between the solubilizing systems. Overall, these findings demonstrate that solubilizing constituents in colonic fluids can substantially increase drug solubility, mucus permeation, and colonic absorption, highlighting the importance of accounting for protein–drug interactions when evaluating drug behavior in the colon.
- 1 January 2020
- Published by Elsevier in Journal of Controlled Release
- Vol. 317, 375-384
Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems
- 1 January 2020
- Published by Elsevier in Journal of Controlled Release
- Vol. 317, 375-384
Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems
- 1 January 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 573, 118862
Comparison of induction methods for supersaturation: pH shift versus solvent shift
- 1 January 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 573, 118862
Comparison of induction methods for supersaturation: pH shift versus solvent shift
- Open Access
- 1 September 2019
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 142, 307-314
Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats
- 1 September 2019
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 142, 307-314
Open AccessDeveloping a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats
- 1 April 2018
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (4) , 1095-1103
Characterization of the Hydrodynamics in a Miniaturized Dissolution Apparatus
- 1 April 2018
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (4) , 1095-1103
Characterization of the Hydrodynamics in a Miniaturized Dissolution Apparatus
- 7 November 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 14 (12) , 4161-4169
Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method
The high number of poorly water-soluble compounds in drug development has increased the need for enabling formulations to improve oral bioavailability. One frequently applied approach is to induce supersaturation at the absorptive site, e.g., the small intestine, increasing the amount of dissolved compound available for absorption. However, due to the stochastic nature of nucleation, supersaturating drug delivery systems may lead to inter- and intrapersonal variability. The ability to define a feasible range with respect to the supersaturation level is a crucial factor for a successful formulation. Therefore, an in vitro method is needed, from where the ability of a compound to supersaturate can be defined in a reproducible way. Hence, this study investigates the reproducibility of an in vitro small scale standardized supersaturation and precipitation method (SSPM). First an intralaboratory reproducibility study of felodipine was conducted, after which seven partners contributed with data for three model compounds; aprepitant, felodipine, and fenofibrate, to determine the interlaboratory reproducibility of the SSPM. The first part of the SSPM determines the apparent degrees of supersaturation (aDS) to investigate for each compound. Each partner independently determined the maximum possible aDS and induced 100, 87.5, 75, and 50% of their determined maximum possible aDS in the SSPM. The concentration–time profile of the supersaturation and following precipitation was obtained in order to determine the induction time (tind) for detectable precipitation. The data showed that the absolute values of tind and aDS were not directly comparable between partners, however, upon linearization of the data a reproducible rank ordering of the three model compounds was obtained based on the β-value, which was defined as the slope of the ln(tind) versus ln(aDS)−2 plot. Linear regression of this plot showed that aprepitant had the highest β-value, 15.1, while felodipine and fenofibrate had comparable β-values, 4.0 and 4.3, respectively. Of the five partners contributing with full data sets, 80% could obtain the same rank order for the three model compounds using the SSPM (aprepitant > felodipine ≈ fenofibrate). The α-value is dependent on the experimental setup and can be used as a parameter to evaluate the uniformity of the data set. This study indicated that the SSPM was able to obtain the same rank order of the β-value between partners and, thus, that the SSPM may be used to classify compounds depending on their supersaturation propensity.
- 7 November 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 14 (12) , 4161-4169
Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method
The high number of poorly water-soluble compounds in drug development has increased the need for enabling formulations to improve oral bioavailability. One frequently applied approach is to induce supersaturation at the absorptive site, e.g., the small intestine, increasing the amount of dissolved compound available for absorption. However, due to the stochastic nature of nucleation, supersaturating drug delivery systems may lead to inter- and intrapersonal variability. The ability to define a feasible range with respect to the supersaturation level is a crucial factor for a successful formulation. Therefore, an in vitro method is needed, from where the ability of a compound to supersaturate can be defined in a reproducible way. Hence, this study investigates the reproducibility of an in vitro small scale standardized supersaturation and precipitation method (SSPM). First an intralaboratory reproducibility study of felodipine was conducted, after which seven partners contributed with data for three model compounds; aprepitant, felodipine, and fenofibrate, to determine the interlaboratory reproducibility of the SSPM. The first part of the SSPM determines the apparent degrees of supersaturation (aDS) to investigate for each compound. Each partner independently determined the maximum possible aDS and induced 100, 87.5, 75, and 50% of their determined maximum possible aDS in the SSPM. The concentration–time profile of the supersaturation and following precipitation was obtained in order to determine the induction time (tind) for detectable precipitation. The data showed that the absolute values of tind and aDS were not directly comparable between partners, however, upon linearization of the data a reproducible rank ordering of the three model compounds was obtained based on the β-value, which was defined as the slope of the ln(tind) versus ln(aDS)−2 plot. Linear regression of this plot showed that aprepitant had the highest β-value, 15.1, while felodipine and fenofibrate had comparable β-values, 4.0 and 4.3, respectively. Of the five partners contributing with full data sets, 80% could obtain the same rank order for the three model compounds using the SSPM (aprepitant > felodipine ≈ fenofibrate). The α-value is dependent on the experimental setup and can be used as a parameter to evaluate the uniformity of the data set. This study indicated that the SSPM was able to obtain the same rank order of the β-value between partners and, thus, that the SSPM may be used to classify compounds depending on their supersaturation propensity.
- 16 August 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 14 (12) , 4154-4160
Development of a Video-Microscopic Tool To Evaluate the Precipitation Kinetics of Poorly Water Soluble Drugs: A Case Study with Tadalafil and HPMC
Many drug candidates today have a low aqueous solubility and, hence, may show a low oral bioavailability, presenting a major formulation and drug delivery challenge. One way to increase the bioavailability of these drugs is to use a supersaturating drug delivery strategy. The aim of this study was to develop a video-microscopic method, to evaluate the effect of a precipitation inhibitor on supersaturated solutions of the poorly soluble drug tadalafil, using a novel video-microscopic small scale setup. Based on preliminary studies, a degree of supersaturation of 29 was chosen for the supersaturation studies with tadalafil in FaSSIF. Different amounts of hydroxypropyl methyl cellulose (HPMC) were predissolved in FaSSIF to give four different concentrations, and the supersaturated system was then created using a solvent shift method. Precipitation of tadalafil from the supersaturated solutions was monitored by video-microscopy as a function of time. Single-particle analysis was possible using commercially available software; however, to investigate the entire population of precipitating particles (i.e., their number and area covered in the field of view), an image analysis algorithm was developed (multiparticle analysis). The induction time for precipitation of tadalafil in FaSSIF was significantly prolonged by adding 0.01% (w/v) HPMC to FaSSIF, and the maximum inhibition was reached at 0.1% (w/v) HPMC, after which additional HPMC did not further increase the induction time. The single-particle and multiparticle analyses yielded the same ranking of the HPMC concentrations, regarding the inhibitory effect on precipitation. The developed small scale method to assess the effect of precipitation inhibitors can speed up the process of choosing the right precipitation inhibitor and the concentration to be used.
- 16 August 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 14 (12) , 4154-4160
Development of a Video-Microscopic Tool To Evaluate the Precipitation Kinetics of Poorly Water Soluble Drugs: A Case Study with Tadalafil and HPMC
Many drug candidates today have a low aqueous solubility and, hence, may show a low oral bioavailability, presenting a major formulation and drug delivery challenge. One way to increase the bioavailability of these drugs is to use a supersaturating drug delivery strategy. The aim of this study was to develop a video-microscopic method, to evaluate the effect of a precipitation inhibitor on supersaturated solutions of the poorly soluble drug tadalafil, using a novel video-microscopic small scale setup. Based on preliminary studies, a degree of supersaturation of 29 was chosen for the supersaturation studies with tadalafil in FaSSIF. Different amounts of hydroxypropyl methyl cellulose (HPMC) were predissolved in FaSSIF to give four different concentrations, and the supersaturated system was then created using a solvent shift method. Precipitation of tadalafil from the supersaturated solutions was monitored by video-microscopy as a function of time. Single-particle analysis was possible using commercially available software; however, to investigate the entire population of precipitating particles (i.e., their number and area covered in the field of view), an image analysis algorithm was developed (multiparticle analysis). The induction time for precipitation of tadalafil in FaSSIF was significantly prolonged by adding 0.01% (w/v) HPMC to FaSSIF, and the maximum inhibition was reached at 0.1% (w/v) HPMC, after which additional HPMC did not further increase the induction time. The single-particle and multiparticle analyses yielded the same ranking of the HPMC concentrations, regarding the inhibitory effect on precipitation. The developed small scale method to assess the effect of precipitation inhibitors can speed up the process of choosing the right precipitation inhibitor and the concentration to be used.
- 1 October 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (10) , 3021-3029
Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach
- 1 October 2016
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (10) , 3021-3029
Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach
- 1 January 2016
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 82, 138-146
Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells
- 1 January 2016
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 82, 138-146
Interaction of GABA-mimetics with the taurine transporter (TauT, Slc6a6) in hyperosmotic treated Caco-2, LLC-PK1 and rat renal SKPT cells